{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:44:45Z","timestamp":1790372685457,"version":"4.1.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T00:00:00Z","timestamp":1739318400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Infantile Epileptic Spasms Syndrome (IESS) is the most common epilepsy syndrome in children with trisomy 21. First-line standard treatments for IESS include adrenocorticotropic hormone (ACTH), oral corticosteroids, and vigabatrin. Among children with trisomy 21 and IESS, treatment with ACTH or oral corticosteroids may yield higher response rates compared with vigabatrin. However, supporting data are largely from single-center, retrospective cohort studies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Leveraging the multi-center, prospective National Infantile Spasms Consortium (NISC) database, we evaluated the efficacy of first-line (standard) treatments for IESS in children with trisomy 21. We assessed clinical spasms remission at two weeks, clinical spasms remission at three months, and improvement of EEG (resolution of hypsarrhythmia) three months after initiation of treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Thirty four of 644 (5.3%) children with IESS were diagnosed with trisomy 21. In all children with trisomy 21, epileptic spasms was their presenting seizure type. Twenty of 34 (59%) children were initially treated with ACTH, nine (26%) with oral corticosteroids, and five (15%) with vigabatrin. Baseline demographics did not vary among treatment groups. The overall clinical remission rate after two weeks of treatment was 53% including 13 of 20 (65%) receiving ACTH, three of nine (33%) receiving oral corticosteroids, and two of five (40%) receiving vigabatrin (<jats:italic>p<\/jats:italic>\u2009=\u20090.24). The continued clinical response rate at three months was 32% including 8 of 20 (40%) receiving ACTH, two of nine (22%) receiving oral corticosteroids, and one of five (20%) receiving vigabatrin. Thirty of the 34 (88%) children presented with hypsarrhythmia (88%). EEG improvement at three months was better for children treated with ACTH (74%) or oral corticosteroids (83%) than vigabatrin (20%; <jats:italic>p<\/jats:italic>\u2009=\u20090.048). Adjustment for time from epileptic spasms onset to treatment did not alter results.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In our cohort, epileptic spasms were the first presenting seizure type in all children with trisomy 21. Among first-line standard treatment options, ACTH may have superior efficacy for clinical and electrographic outcomes for IESS in children with trisomy 21.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2025.1498425","type":"journal-article","created":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T07:26:15Z","timestamp":1739345175000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Treatment efficacy for infantile epileptic spasms syndrome in children with trisomy 21"],"prefix":"10.3389","volume":"13","author":[{"given":"Henry","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam L.","family":"Numis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9e A.","family":"Shellhaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Mytinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debopam","family":"Samanta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rani K.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaun A.","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Takacs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly G.","family":"Knupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Rong","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl E.","family":"Stafstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1469-8749.1991.tb05108.x","article-title":"Seizures in children with Down syndrome: etiology, characteristics and outcome","volume":"33","author":"Stafstrom","year":"1991","journal-title":"Dev Med Child Neurol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1111\/j.1528-1157.1996.tb00535.x","article-title":"Early clinical and EEG features of infantile spasms in Down syndrome","volume":"37","author":"Silva","year":"1996","journal-title":"Epilepsia"},{"key":"B3","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/j.1469-8749.1994.tb11894.x","article-title":"Infantile spasms in children with Down syndrome","volume":"36","author":"Stafstrom","year":"1994","journal-title":"Dev Med Child Neurol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1684\/epd.2011.0415","article-title":"Epilepsy in children with Down syndrome","volume":"13","author":"Arya","year":"2011","journal-title":"Epileptic Disord"},{"key":"B5","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/epi4.12412","article-title":"Epileptic spasms in individuals with Down syndrome: a review of the current literature","volume":"5","author":"Kats","year":"2020","journal-title":"Epilepsia Open"},{"key":"B6","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1535-7511.2006.00100.x","article-title":"Infantile spasms: little seizures, BIG consequences","volume":"6","author":"Shields","year":"2006","journal-title":"Epilepsy Curr"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1111\/epi.17239","article-title":"ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: position statement by the ILAE task force on nosology and definitions","volume":"63","author":"Zuberi","year":"2022","journal-title":"Epilepsia"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1111\/epi.17237","article-title":"Methodology for classification and definition of epilepsy syndromes with list of syndromes: report of the ILAE task force on nosology and definitions","volume":"63","author":"Wirrell","year":"2022","journal-title":"Epilepsia"},{"key":"B9","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.seizure.2016.12.016","article-title":"Diagnosis, treatment, and outcomes of infantile spasms in the trisomy 21 population","volume":"45","author":"Beatty","year":"2017","journal-title":"Seizure"},{"key":"B10","first-page":"344","article-title":"Intellectual disability and epielpsy in Down syndrome","volume":"9","author":"Barca","year":"2014","journal-title":"Maedica"},{"key":"B11","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.1007\/s00415-020-10179-w","article-title":"Neurologic complications of Down syndrome: a systematic review","volume":"268","author":"Santoro","year":"2021","journal-title":"J Neurol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1055\/s-0035-1556768","article-title":"Neurodevelopmental outcomes in children with Down syndrome and infantile spasms","volume":"13","author":"Tapp","year":"2015","journal-title":"J Pediatr Neurol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1016\/S0140-6736(04)17400-X","article-title":"The United Kingdom infantile spasms study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial","volume":"364","author":"Lux","year":"2004","journal-title":"Lancet"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1212\/WNL.0b013e318259e2cf","article-title":"Evidence-based guideline update: medical treatment of infantile spasms. Report of the guideline development subcommittee of the American Academy of Neurology and the practice committee of the Child Neurology Society","volume":"78","author":"Go","year":"2012","journal-title":"Neurology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1212\/WNL.0000000000004806","article-title":"Quality improvement in neurology: child neurology quality measure set: executive summary","volume":"90","author":"Patel","year":"2018","journal-title":"Neurology"},{"key":"B16","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/S2352-4642(18)30244-X","article-title":"Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial","volume":"2","author":"O'Callaghan","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e1217","DOI":"10.1212\/WNL.0000000000012511","article-title":"Comparative effectiveness of initial treatment for infantile spasms in a contemporary US cohort","volume":"97","author":"Grinspan","year":"2021","journal-title":"Neurology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/epi.17808","article-title":"Fifteen years of real-world data on the use of vigabatrin in individuals with infantile epileptic spasms syndrome","volume":"65","author":"Kuchenbuch","year":"2024","journal-title":"Epilepsia"},{"key":"B19","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/ana.25956","article-title":"Prevention of epilepsy in infants with tuberous sclerosis complex in the EPISTOP trial","volume":"89","author":"Kotulska","year":"2021","journal-title":"Ann Neurol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1055\/a-1909-2977","article-title":"Treatment of infantile spasm syndrome: update from the interdisciplinary guideline committee coordinated by the German-speaking Society of Neuropediatrics","volume":"53","author":"Ramantani","year":"2022","journal-title":"Neuropediatrics"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2333794X18821939","DOI":"10.1177\/2333794X18821939","article-title":"Infantile spasms in children with Down syndrome: identification and treatment response","volume":"6","author":"Daniels","year":"2019","journal-title":"Glob Pediatr Health"},{"key":"B22","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/ana.24594","article-title":"Response to treatment in a prospective National Infantile Spasms Cohort","volume":"79","author":"Knupp","year":"2016","journal-title":"Ann Neurol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1111\/epi.13937","article-title":"The impact of hypsarrhythmia on infantile spasms treatment response: observational cohort study from the National Infantile Spasms Consortium","volume":"58","author":"Demarest","year":"2017","journal-title":"Epilepsia"},{"key":"B24","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S1474-4422(16)30294-0","article-title":"Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial","volume":"16","author":"O'Callaghan","year":"2017","journal-title":"Lancet Neurol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.yebeh.2018.12.013","article-title":"Brain MRI abnormalities in patients with infantile spasms and Down syndrome","volume":"92","author":"Trowbridge","year":"2019","journal-title":"Epilepsy Behav"},{"key":"B26","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1111\/dmcn.15153","article-title":"Response to treatment and outcomes of infantile spasms in Down syndrome","volume":"64","author":"Harvey","year":"2022","journal-title":"Dev Med Child Neurol"},{"key":"B27","first-page":"213","article-title":"Infantile spasms in children with Down syndrome","volume":"35","author":"Luji\u0107","year":"2011","journal-title":"Coll Antropol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1017\/cjn.2021.12","article-title":"Infantile spasms and trisomy 21: unfavorable outcomes with first-line vigabatrin therapy","volume":"48","author":"Datta","year":"2021","journal-title":"Can J Neurol Sci"},{"key":"B29","article-title":"Infantile epileptic spasm syndrome and trisomy 21: treatment response and outcomes","author":"Glineur","year":"2024"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.1111\/epi.16305","article-title":"The underlying etiology of infantile spasms (west syndrome): information from the International Collaborative Infantile Spasms Study (ICISS)","volume":"60","author":"Osborne","year":"2019","journal-title":"Epilepsia"},{"key":"B31","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.pediatrneurol.2012.09.006","article-title":"Treatment outcomes of West syndrome in infants with Down syndrome","volume":"48","author":"Sanmaneechai","year":"2013","journal-title":"Pediatr Neurol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1111\/j.1528-1167.2011.03127.x","article-title":"The effect of lead time to treatment and of age of onset on developmental outcome at 4 years in infantile spasms: evidence from the United Kingdom Infantile Spasms Study","volume":"52","author":"O'Callaghan","year":"2011","journal-title":"Epilepsia"},{"key":"B33","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3978\/j.issn.2224-4336.2015.09.01","article-title":"Management of infantile spasms","volume":"4","author":"Nelson","year":"2015","journal-title":"Transl Pediatr"},{"key":"B34","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3390\/children7010005","article-title":"Infantile spasms: an update on pre-clinical models and EEG mechanisms","volume":"7","author":"Janicot","year":"2020","journal-title":"Children (Basel)"},{"key":"B35","first-page":"105","article-title":"Implications of delayed diagnosis of infantile spasm in a child with Down syndrome","volume":"12","author":"Buterbaugh","year":"2014","journal-title":"J Pediatr Neurol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"113387","DOI":"10.1016\/j.jpeds.2023.02.035","article-title":"The effect of smartphone video on lead time to diagnosis of infantile spasms","volume":"258","author":"Rao","year":"2023","journal-title":"J Pediatr"},{"key":"B37","doi-asserted-by":"publisher","first-page":"113442","DOI":"10.1016\/j.jpeds.2023.113442","article-title":"Can a smartphone jump start care for infantile spasms?","volume":"258","author":"Wusthoff","year":"2023","journal-title":"J Pediatr"},{"key":"B38","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/epi.16733","article-title":"Design and implementation of electronic health record common data elements for pediatric epilepsy: foundations for a learning health care system","volume":"62","author":"Grinspan","year":"2021","journal-title":"Epilepsia"},{"key":"B39","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1111\/epi.12861","article-title":"Hypsarrhythmia assessment exhibits poor interrater reliability: a threat to clinical trial validity","volume":"56","author":"Hussain","year":"2015","journal-title":"Epilepsia"},{"key":"B40","doi-asserted-by":"publisher","first-page":"106631","DOI":"10.1016\/j.eplepsyres.2021.106631","article-title":"A reliable interictal EEG grading scale for children with infantile spasms\u2014the 2021 BASED score","volume":"173","author":"Mytinger","year":"2021","journal-title":"Epilepsy Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1097\/WNP.0000000000001101","article-title":"A multicenter training and interrater reliability study of the BASED score for infantile epileptic spasms syndrome","author":"Mytinger","year":"2024","journal-title":"J Clin Neurophysiol"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1498425\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,12]],"date-time":"2025-02-12T07:26:20Z","timestamp":1739345180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2025.1498425\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,12]]},"references-count":41,"alternative-id":["10.3389\/fped.2025.1498425"],"URL":"https:\/\/doi.org\/10.3389\/fped.2025.1498425","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,12]]},"article-number":"1498425"}}